PCN66 - Pharmacoeconomic Aspects of Different Inhibitors of Tyrosine Kinase in First-Line Therapy of Patients with Advanced Non-Small Cell Lung Cancer with A Mutation in Epidermal Growth Factor Receptor (EGFR) Gene
| Autor: | Ryazhenov, VV, Gorokhova, SG, Gorokhov, V |
|---|---|
| Zdroj: | In Value in Health November 2016 19(7):A720-A720 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect